von Willebrand Disease (VWF) sequencing-994

Test info

  
von Willebrand Disease (VWF) sequencing
  
994
  
LAB994
  
MSO
  
von Willebrand disease (VWD)
von Willebrand factor deficiency
VWD type 1
VWD type 2
VWD type 2A
VWD type 2M
VWD type 3
VWD type B
VWF gene
  
  • Molecular test to confirm a phenotypic diagnosis of von Willebrand disease (VWD) types 1, 2A, 2B, 2M, 2N, or 3.
  • May also be used as carrier screening for autosomal recessive forms of VWD.

Specimen

  
EDTA whole blood
  
  
3 mL
  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting

  

Lavender (EDTA), 4mL

  
ACD whole blood
  

Yellow ACD (A or B)

 

  

Yellow ACD (A or B)

  

Refrigerated (preferred) - 2 weeks

Ambient – 72 hours

Frozen – NO

  
  • Serum or plasma
  • Grossly hemolyzed specimens
  • Frozen specimens

Performance

  
ARUP Laboratories Inc (3004379) via Labcorp (009985): R-NX
  
10-15 days
  

Massively Parallel Sequencing

Clinical and Interpretive info

  

See report

Billing

  
81408
  
Yes
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed

Molecular Medicare billing request

Tracking

  
03/01/2022
  
12/18/2023
  
12/18/2023